You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Systemic lupus erythematosus

Belimumab for treating lupus nephritis (terminated appraisal)

  • Technology appraisal
  • Reference number: TA806
  • Published:  13 July 2022
  • Guidance
  • Tools and resources
  • History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top